Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Stroke. 2007;38:259-263
Published online before print December 28, 2006, doi: 10.1161/01.STR.0000254622.52483.03
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/2/259    most recent
01.STR.0000254622.52483.03v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andersen, K. K.
Right arrow Articles by Olsen, T. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andersen, K. K.
Right arrow Articles by Olsen, T. S.
Related Collections
Right arrow Secondary prevention
Right arrow Cerebrovascular disease/stroke
Right arrow Risk Factors
Right arrow Coumarins
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Embolic stroke

(Stroke. 2007;38:259.)
© 2007 American Heart Association, Inc.

Original Contributions

Reduced Poststroke Mortality in Patients With Stroke and Atrial Fibrillation Treated With Anticoagulants

Results From a Danish Quality-Control Registry of 22 179 Patients With Ischemic Stroke

Klaus Kaae Andersen, MS, PhD Tom Skyhøj Olsen, MD, PhD

From the Department of Informatics and Mathematical Modelling (K.K.A.), Section for Statistics, Technical University of Denmark, Lyngby, and the Stroke Unit (T.S.O.), Hvidovre University Hospital, Hvidovre, Denmark.

Correspondence to Tom Skyhøj Olsen, MD, PhD, Stroke Unit, Department of Neurorehabilitation, Hvidovre University Hospital, Kettegaard Allé 30, DK-2650 Hvidovre, Denmark. E-mail Tom.Skyhoej.Olsen{at}hh.hosp.dk

Background and Purpose— The preventive effect of anticoagulation in patients with stroke and atrial fibrillation (AF) is documented only in trials of minor stroke. Although anticoagulation reduced stroke recurrence, those trials did not demonstrate an influence of anticoagulation on survival.

Methods— A nationwide registry that was started in 2001 with the aim of registering all hospitalized stroke patients in Denmark now includes 24 791 patients. We studied the survival of patients with ischemic stroke and AF with respect to anticoagulation treatment. All underwent an evaluation for stroke severity (according to the Scandinavian Stroke Scale), computed tomography scan, and an evaluation for cardiovascular risk factors. Follow-up duration was 4 years (mean, 1.2 years).

Results— Of all patients, 22 179 (89.4%) experienced an ischemic stroke. In total, 3670 (16.5%) had AF, and 1909 had no contraindication to anticoagulation treatment. Anticoagulation treatment was initiated in 1149 of these patients (60.2%) but omitted in 760 (39.8%) despite no contraindication to such treatment. Of the patients so treated, 18.9% died during follow-up versus 45.2% without treatment. Patients who received treatment were younger (76.7±9.5 versus 80.7±9.0 years, P<0.0001) and had less severe strokes (Scandinavian Stroke Scale score, 42.0±15.0 versus 33.6±18.2, P<0.0001). A Cox proportional-hazards model was built to study the effect of anticoagulation on survival in patients without contraindications to treatment while controlling for stroke severity, sex, and cardiovascular risk factors. Patients without anticoagulation treatment were at greater risk of dying (hazard ratio=1.91, 95% CI=1.44 to 2.52) compared with patients who received anticoagulation treatment.

Conclusions— Our data suggest that anticoagulation treatment reduces poststroke mortality in patients with ischemic stroke and AF.


Key Words: anticoagulation • atrial fibrillation • prevention • prognosis • stroke




This article has been cited by other articles:


Home page
 ESC Textbook of Cardiovascular MedicineHome page
A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst
CHAPTER 29 Atrial Fibrillation
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. Stoll, C. Kleinschnitz, and B. Nieswandt
Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment
Blood, November 1, 2008; 112(9): 3555 - 3562.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
B. Wettermark, A. Persson, and M. von Euler
Secondary Prevention in a Large Stroke Population: A Study of Patients' Purchase of Recommended Drugs
Stroke, October 1, 2008; 39(10): 2880 - 2885.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
H. Gulbins, I. Florath, and J. Ennker
Cerebrovascular Events After Stentless Aortic Valve Replacement During a 9-Year Follow-Up Period
Ann. Thorac. Surg., September 1, 2008; 86(3): 769 - 773.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. Covic, P. Gusbeth-Tatomir, and D. Goldsmith
Negative outcome studies in end-stage renal disease: how dark are the storm clouds?
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 56 - 61.
[Full Text] [PDF]

Home page
 StrokeHome page
G. Tsivgoulis, S. Vassilopoulou, and K. Spengos
Impact of Anticoagulation on Poststroke Mortality in Ischemic Stroke Patients With Atrial Fibrillation
Stroke, July 1, 2007; 38(7): e61 - e61.
[Full Text] [PDF]

Home page
 StrokeHome page
K. K. Andersen and T. S. Olsen
Response to Letter by Tsivgoulis et al
Stroke, July 1, 2007; 38(7): e62 - e62.
[Full Text] [PDF]


Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.